Europe Heparin Market: Heparin Most Widely Used in Hospitals Across Europe
Bayer HealthCare reports that the number of blood-clot-related deaths in Europe supersede the total number of deaths attributed HIV/AIDS, prostate cancer and breast cancer. This reflects the need for anticoagulants before, during, and after surgical procedures or while a patient is undergoing treatment for neurological disorders and cancer. This brings heparin, a widely used anticoagulant, into focus.
View full press release